Over the past couple of years, I’ve been relentlessly pestered by my dentist’s office. I’ve lost track of the frequency of texts, emails and phone calls. When the overt neediness increased even more at the end of last year, I realized it had barely been six months since our last date. Is it just me […]
Taking a look at private drug plans in 2020, a number of trends are converging: spending on specialty drugs is continuing its upward trajectory, advancements in a number of lifechanging therapies are in the pipeline and policy developments are coming at both the federal and provincial levels. In the face of this potential storm, plan […]
With prescription drugs and paramedical benefits taking up an increasingly large portion of employers’ benefits spend, dental benefits often avoid the spotlight. But consultants and insurers are emphasizing a few dental issues for plan sponsors to consider in 2020. Over-billing Though GE Canada isn’t focusing on dental benefits in this year’s renewal process, Diana McNiven, […]
Green Shield Canada is launching a benefits plan analytics tool to help plan sponsors take a closer look at their offerings. The tool, DATAleap, looks to provide insight on claims trends, key cost drivers and disease state data. It also provides benchmarking tools for plans and demographics analyses. Read: Harnessing analytics, data to support employee mental health “Users can […]
Historically, Epcor Utilities Inc. provided employees with $1,000 in annual coverage for each paramedical service, ranging from massage therapists, physiotherapists and chiropractors to speech therapists, naturopaths and dieticians. But in 2018, the Edmonton-based utilities company looked at its annual paramedical costs and found its massage therapy spend had ballooned to nearly match the cost of […]
Workplace mental-health programs can demonstrate a huge return on investment for an organization’s bottom line, as well as reducing absenteeism and presenteeism, said Nir Yahav, mental-health specialist on the national disability best practices team at Manulife, during a session at Benefits Canada’s 2019 Vancouver Mental Health Summit on Dec. 12. There are huge costs associated with presenteeism, […]
While 2.7 million Canadians suffer from migraine, the condition can be subdivided based on its frequency, said Dr. Esma Dilli, neurologist and clinical assistant professor at the University of British Columbia, during Benefits Canada’s 2019 Vancouver Mental Health Summit on Dec. 12. Episodic migraine is defined by less than 15 headache days a month, whereas […]
While insomnia is a disorder, it’s just as commonly a symptom, which most people and physicians don’t grasp, said Dr. Atul Khullar, medical director at the Northern Alberta Sleep Clinic. A lot of times, not sleeping is essentially the body breaking down because of a separate disorder, risk factor or residual symptom of a mental-health […]
While high-cost specialty medications represent about 30 per cent of drug costs, the total budget impact of rare disease drugs is less than two per cent, said Brad McCaw, associate director of market access at Alexion Pharmaceuticals Canada. Within the high-cost specialty market’s top 20 drugs, only one is designated for rare disease, he said […]
Brand-name drug companies could put off introducing new medicine in Canada and scale back research here if the country makes a major shift to cheaper generic alternatives under a national pharmacare plan, according to an internal federal analysis. The concerns were included last year in a briefing document for federal Finance Minister Bill Morneau that […]